CurrentBlue Cross Blue Shield - New MexicoPolicy CPCP026

Therapeutic, Prophylactic and Diagnostic Injection and Infusion Coding

Governance for coding, billing, documentation, and reimbursement of therapeutic, prophylactic, diagnostic injections and infusions (including hydration and chemotherapy/highly complex agents) for providers submitting claims to BCBSNM.

Policy Summary

PayerBlue Cross Blue Shield - New Mexico

PolicyTherapeutic, Prophylactic and Diagnostic Injection and Infusion Coding

Policy CodePolicy CPCP026

Change TypeNo material change

Effective DateMay 15, 2023

Next Review Date

Key ActionDocument and retain supporting medical records; provide drug name, code, dosage and a $0.00 charge line when a member supplies their own drug and report CPT 96372 for administration if no E/M is provided.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

96360-96361hydration CPT range

96365-96377injection/infusion CPT range

96401-96549chemotherapy CPT range

3policy reviews

Coverage and Reimbursement Criteria

Reimbursement criteria and billing rules

Services, supplies, and coding conditions that affect separate reimbursement:

Supplies and routine items integral to infusion/injection (e.g., standard tubing, syringes, flush, IV start, local anesthesia, access to indwelling IV/subcutaneous catheter or port) are not separately reimbursed when provided during the same encounter.

Hydration codes require a minimum duration (see coding section) and fluids used solely as vehicle for drug administration are incidental and not separately reimbursed.

Only one initial infusion service code should be reported per date of service unless protocol or patient condition requires two separate IV sites.

If multiple drugs are administered, report the service(s) and the specific materials or drugs for each injection type; when multiple infusions/injections are given, report only one initial service code for a given date unless protocol requires otherwise.

Services that are mutually exclusive, integral, incidental, or within the global period of a primary service are not eligible for separate reimbursement.

A significant, separately identifiable E/M service performed on the same day as an infusion/injection may be reported with modifier -25 when documentation supports the separate service.

Use of modifier -59 may indicate a distinct procedural service when supported by documentation; use other appropriate modifiers as applicable.

JW modifier should be used to report discarded amounts of drug/biologic on a separate line with a zero-dollar charge for non-inpatient places of service, and documentation must identify the drug, dosage, and reason for discard.

Certain add-on or facility-only codes (for example +96376) may be facility-specific; facilities and providers should reference related home infusion and coding policies for appropriate use.

Vaccination administration should be billed with the appropriate administration and vaccine codes; an E/M should not be billed with immunizations unless it is separately identifiable (append modifier -25).

Providers must retain accurate documentation (orders, drug name/dosage, start/stop times, infusion rate, monitoring, and signatures) as the Plan may request supporting documentation and claims are reviewed case-by-case.

Chemotherapy and other highly complex agent administration require appropriate advanced staffing, direct supervision, and should be billed using the chemotherapy/highly complex agent CPT ranges where applicable.

When a member supplies their own drug and it is administered under direct supervision, document CPT 96372 (if no E/M service) and include the drug name, code, dosage and bill the drug with a $0.00 charge line.

Claims must be coded using HIPAA-approved code sets and follow standard coding guidelines; the Plan may apply coding edits and adjudicate claims per provider contract and plan documents.

Immunization and member-supplied drug billing criteria

Billing and documentation requirements for immunizations and member-supplied drugs

Vaccinations must be billed using the appropriate administration and vaccine codes; E/M services should not be billed with immunizations unless the E/M is separately identifiable and modifier -25 is appended.

Documentation may be required to support separate reimbursement for an E/M performed on the same day as an immunization.

If a member supplies their own drug for provider administration and the drug is given under direct supervision, document CPT 96372 if no E/M is provided, and record the drug name, drug code, drug dosage and bill the drug line with a zero-dollar ($0.00) charge.

CPT/HCPCS Coding Guidance

HydrationCPT

96360-96361

Hydration IV infusion codes

Therapeutic/Prophylactic/Diagnostic injections/infusionsCPT

96365-96377, 96379	Therapeutic, prophylactic, diagnostic IV infusions and injections (excluding chemotherapy)
96372	Therapeutic/prophylactic/diagnostic SC/IM injection
+96376	Facility-only sequential injection same drug

Chemotherapy / Highly complex agentsCPT

96401-96549

Chemotherapy / highly complex drug or biologic administration

Drug waste reportingModifier

JW	Modifier to report discarded amount of drug/biologic

Member-supplied drug administrationCPTCovered

96372

Therapeutic, prophylactic, or diagnostic injection (member-supplied drug administration)

inv-08: Minimum hydration infusion duration

Minimum hydration infusion durationHydration CPT codes (96360-96361) require a minimum infusion time of 31 minutes to report the service

When not reportableDo not report hydration codes when IV fluids are given to keep an IV line open or as free‑flowing IV during other therapeutic infusions (e.g., chemotherapy)

Supervision requirementHydration IV infusions usually require direct supervision for consent, safety oversight, or intra‑service staff supervision

inv-09: Documentation threshold

E/M with immunizationsE/M services should not be billed with immunizations unless the E/M is separately identifiable; append modifier -25 to the E/M to indicate a separate service

Documentation for separate reimbursementDocumentation may be required to permit separate reimbursement when an E/M is billed with an immunization

Member‑supplied drug documentationIf a member supplies their own drug, document the drug name, drug code, drug dosage and bill the drug with a $0.00 charge; include CPT 96372 for administration if no E/M is provided

Provider Responsibilities and Billing Actions

Documentation Required

Documentation upon request

The Plan reserves the right to request supporting documentation. Documentation may be used to validate services billed and care rendered to a member. Failure to adhere to coding and billing policies may impact claims processing and reimbursement. Claims are reviewed on a case-by-case basis. Submission of any code should be fully supported in the medical documentation. Services that are considered mutually exclusive, integral to, incidental or within the global period of a primary service are not eligible for separate reimbursement.

Note

Policy precedence and plan/provider discretion

If a conflict arises between this Clinical Payment and Coding Policy (CPCP) and any plan document under which a member is entitled to Covered Services, the plan document will govern. If a conflict arises between this CPCP and any provider contract pursuant to which a provider participates in and/or provides Covered Services to eligible member(s) and/or plans, the provider contract will govern. BCBSNM may use reasonable discretion in interpreting and applying this policy to services being delivered in a particular case and has full and final discretionary authority for interpretation and application to the extent provided under any applicable plan documents. Providers are responsible for submission of accurate documentation and for coding claims using HIPAA-approved code sets and industry standard coding guidelines.

Billing Rule

Vaccination billing and E/M separation

Vaccinations/immunizations must be billed with the appropriate vaccine and administration codes. Evaluation and management (E/M) services should not be billed in conjunction with immunizations unless the E/M represents a separately identifiable service. When an E/M is separately identifiable, append modifier -25 to the E/M code and retain documentation to support separate reimbursement; documentation may be requested by the Plan.

Documentation Required

Member-supplied drugs documentation

When a member supplies their own drug (no cost to the provider) and the drug is administered under direct supervision, document the administration appropriately. Include CPT 96372 if no E/M service is provided, and record the drug name, drug code, dosage, and a zero-dollar ($0.00) charge in the medical record and claim documentation.

Definitions and Terminology

inv-14: Injection

DefinitionIntroduction of a substance into the body using a syringe and an attached needle; may be subcutaneous, intravenous, intramuscular, or intrathecal.

RoutesCommon routes include subcutaneous (under the skin), intravenous (into a vein), intramuscular (deep into a muscle), and intrathecal (into spinal fluid)

Context of useInjections are reported using CPT codes for therapeutic, prophylactic, or diagnostic injections when applicable

inv-15: Infusion

DefinitionIntravenous or subcutaneous administration of therapeutic solutions (e.g., saline); often referred to as a drip.

Typical usesUsed in treatment of dehydration, hypoglycemia, or other plasma/electrolyte imbalances

Coding noteInfusions are reported using appropriate CPT infusion codes; hydration has specific CPT codes and time thresholds

inv-16: Initial Infusion

DefinitionInitial infusion is the primary reason for the encounter; report only one initial service code unless protocol or the member's condition requires two separate IV sites.

Reporting guidanceInitial infusion is reported irrespective of temporal order of services and applies to physician/QHP reporting and facility reporting (facility uses hierarchy)

ExceptionIf two separate IV sites are required by protocol or patient condition, report a separate initial service code for the second site

inv-17: Intravenous/Intra-arterial Push

DefinitionAn injection/infusion where the individual administering the drug is continuously present to administer and observe the member, or any infusion of 15 minutes or less.

Time thresholdIncludes infusions of 15 minutes or less as intravenous/intra‑arterial push

Supervision implicationContinuous presence of the administrator is a defining characteristic for an IV/intra‑arterial push

inv-18: Qualified Healthcare Professional (QHP)

DefinitionIndividual qualified by education, training, licensure/regulation and facility privileging who performs and independently reports professional services.

ScopeQHPs perform professional services within their scope of practice and independently report those services

RelevanceUsed to define who may report initial infusion services and professional-level billing

inv-19: Sequential and Concurrent Infusion

Sequential infusionA new substance or drug is infused following an initial service; sequential services require a new substance except facilities may report a sequential IV push of the same drug with CPT 96376

Concurrent infusionA new substance infused at the same time as another substance; concurrent services are not time based and are reported only once per day regardless of additional concurrent drugs

Hydration exceptionHydration may not be reported concurrently with any other service

inv-20: Modifier -25 indicates a separately identifiable E/M service on the same day as another procedure or service

Modifier -25 meaningModifier -25 indicates a separately identifiable E/M service on the same day as another procedure or service and should be appended to the E/M code when appropriate

Application with immunizationsAppend -25 when the E/M represents a separately identifiable service performed with an immunization; documentation may be required

Documentation requirementProper documentation is required to support separate reimbursement when using modifier -25

inv-21: Member-supplied drug billing

Billing when member supplies drugIf a member supplies their own drug for provider administration, document the drug name, code and dosage and bill the drug with a $0.00 charge; include CPT 96372 for administration if no E/M is provided

Documentation specificsRecords must include drug name, drug code and dosage when a member‑supplied drug is administered

Charge line guidanceProvider should bill the drug line at a zero‑dollar charge to reflect no cost to the provider

Policy Summary

PayerBlue Cross Blue Shield - New Mexico

PolicyTherapeutic, Prophylactic and Diagnostic Injection and Infusion Coding

Policy CodePolicy CPCP026

Change TypeNo material change

Effective DateMay 15, 2023

Next Review Date

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.